On 22 March, the European Medicines Agency (EMA) issued a statement [0] that, after reviewing the evidence, they recommend against the use of ivermectin for the prevention and treatment of covid-19, outside of ‘well-designed’ clinical trials.
Weltweit vereint mit Integrität und richtigem Handeln.